# |
PMID |
Sentence |
1 |
16956892
|
ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart.
|
2 |
16956892
|
Chondroitinase ABC deglycosylation analysis or cell incubation with p-nitrophenyl-beta-d-xyloside indicated that apolipoprotein O belongs to the proteoglycan family.
|
3 |
16956892
|
Naringenin or CP-346086 treatments indicated that apolipoprotein O secretion requires microsomal triglyceride transfer protein activity.
|
4 |
16956892
|
ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart.
|
5 |
16956892
|
Chondroitinase ABC deglycosylation analysis or cell incubation with p-nitrophenyl-beta-d-xyloside indicated that apolipoprotein O belongs to the proteoglycan family.
|
6 |
16956892
|
Naringenin or CP-346086 treatments indicated that apolipoprotein O secretion requires microsomal triglyceride transfer protein activity.
|
7 |
16956892
|
ApoO, a novel apolipoprotein, is an original glycoprotein up-regulated by diabetes in human heart.
|
8 |
16956892
|
Chondroitinase ABC deglycosylation analysis or cell incubation with p-nitrophenyl-beta-d-xyloside indicated that apolipoprotein O belongs to the proteoglycan family.
|
9 |
16956892
|
Naringenin or CP-346086 treatments indicated that apolipoprotein O secretion requires microsomal triglyceride transfer protein activity.
|